NCT06881160View on ClinicalTrials.gov

Mi-RNA and COVID-19

RecruitingOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 1, 2027

Conditions
COVID-19
Interventions
DIAGNOSTIC_TEST

mi-RNA analysis

To identify biomarkers that could predict the risk of a worsened COVID-19 disease progression.

Trial Locations (1)

00167

RECRUITING

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT06881160 - Mi-RNA and COVID-19 | Biotech Hunter | Biotech Hunter